Ramtin Agah Renovo Rx, Inc. (RNXT) insider trading activity

Ramtin Agah is Chief Medical Officer of RenovoRx, Inc.. Currently has a direct ownership of 788,460 shares of RNXT, which is worth approximately $591,345. The most recent transaction as insider was on Dec 31, 2025, when has been sold 9,795 shares (Common Stock) at a price of $0.86 per share, resulting in proceeds of $8,423. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 788K

7.35% 3M change

1561.31% 12M change

Total Value Held $591,345

Ramtin Agah Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 31 2025	BUY Open market or private purchase	$8,423 $0.86 p/Share	9,795 Added 1.23%	788,460 Common Stock
Dec 30 2025	BUY Open market or private purchase	$170 $0.83 p/Share	205 Added 0.03%	778,665 Common Stock
Dec 16 2025	BUY Open market or private purchase	$10,200 $0.85 p/Share	12,000 Added 1.52%	778,460 Common Stock
Dec 05 2025	BUY Open market or private purchase	$9,600 $0.96 p/Share	10,000 Added 1.29%	766,460 Common Stock
Nov 24 2025	BUY Open market or private purchase	$9,600 $0.8 p/Share	12,000 Added 1.56%	756,460 Common Stock
Nov 21 2025	BUY Open market or private purchase	$8,000 $0.8 p/Share	10,000 Added 1.33%	744,460 Common Stock
Jun 05 2025	BUY Open market or private purchase	$29,399 $1.4 p/Share	21,000 Added 2.78%	734,460 Common Stock

Apr 22 2025	SELL Bona fide gift	-	400,000 Reduced 35.92%	713,460 Common Stock
Apr 15 2025	BUY Open market or private purchase	$13,500 $0.9 p/Share	15,000 Added 1.33%	1,113,460 Common Stock
Apr 11 2025	BUY Open market or private purchase	$16,000 $0.8 p/Share	20,000 Added 1.79%	1,098,460 Common Stock
Apr 09 2025	BUY Open market or private purchase	$24,300 $0.81 p/Share	30,000 Added 2.71%	1,078,460 Common Stock
Apr 08 2025	BUY Open market or private purchase	$21,840 $0.84 p/Share	26,000 Added 2.42%	1,048,460 Common Stock
Jan 26 2024	BUY Open market or private purchase	-	40,983 Added 46.34%	47,460 Common Stock
Jun 07 2022	BUY Open market or private purchase	$10,001 $1.93 p/Share	5,182 Added 44.45%	6,477 Common Stock
Mar 16 2022	SELL Bona fide gift	-	975,000 Reduced 99.87%	1,295 Common Stock
Aug 30 2021	BUY Conversion of derivative security	-	1,295 Added 0.13%	976,295 Common Stock

Ramtin Agah

Chief Medical Officer

Los Altos,, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNXT shares.

Notify only if

Value

Insider Trading

Get notified when an Renovo Rx, Inc. insider buys or sells RNXT shares.

Notify only if

Operation

Value

Type

News

Receive news related to RenovoRx, Inc.

Track Activities on RNXT

Account